Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Doxifluridine is an intermediary prodrug of fluorouracil (Item No. 14416), the pyrimidine analog that inhibits thymidylate synthase selectively in tumor cells, interfering with DNA synthesis.1,2,3,4 Doxifluridine is one of two intermediary metabolites formed during metabolic conversion of the chemotherapeutic prodrug, capecitabine (Item No. 10487), to fluorouracil.4
WARNING This product is not for human or veterinary use.
1. Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-
2. Contribution of chitosan and its derivatives to cancer chemotherapy. In Vivo 19, 301-310 (2005).
3. Depression of phenytoin metabolic capacity by 5-
4. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-